Metraipolis › archive › dc_ecc33042dbbd

Rational Design and Evaluation of Novel TGR5 Agonists for Diabetes — Europe PMC PMID:41976136

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41976136
DOI: 10.3390/molecules31071093
License (as archived): solo-consultazione
Archived: 2026-11-03T20:34:21.717Z
SHA-256 of the archived text: 8c231c388d2111c13c4a78f70de786d160d1a56dbe05c4ed0bce10c64cc27d07
Stable URL of this page: https://metraipolis.com/documento/dc_ecc33042dbbd

How to cite

Rational Design and Evaluation of Novel TGR5 Agonists for Diabetes — Europe PMC PMID:41976136 — Europe PMC (en), https://europepmc.org/article/MED/41976136 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ecc33042dbbd (Metraipolis archive dc_ecc33042dbbd, sha256 8c231c388d2111c13c4a78f70de786d160d1a56dbe05c4ed0bce10c64cc27d07)

BibTeX

@misc{dcecc33042dbbd,
  title = {Rational Design and Evaluation of Novel TGR5 Agonists for Diabetes — Europe PMC PMID:41976136},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41976136},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ecc33042dbbd; sha256 8c231c388d2111c13c4a78f70de786d160d1a56dbe05c4ed0bce10c64cc27d07},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41976136. Agents can read the archived copy with the MCP tool read_document.